Skip to main content
Yingying Yu on Muck Rack

Yingying Yu

As seen in: Environmental Health Perspectives, Color Research & Application, Nature, Wiley Online Library, PLOS, BMJ Open, Frontiers, Frontiers in Immunology, Frontiers in Public Health, MDPI and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingying

Contact Yingying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Brown fat-specific RNA labelling reveals a network of inter-organ communication by secreted microRNAs

|
By Marsel Lino, Vissarion Efthymiou, Alice Rodrigues, Allah nawaz, Anindya Ghosh, Bruna Brasil Brandao, Yoshiyuki Watanabe, Rafael Salgueiro, Yingying Yu, C. Ronald Kahn, Gabriel Palermo-Ruiz, Shraddha Bhonsle
| Nature Verified
Abstract Extracellular microRNAs (miRNAs) are emerging as key regulators of organismal homeostasis. Here, using tissue-specific RNA labelling based on uracil phosphoribosyltransferase-mediated incorporation of 4-thiouracil in male mice, we develop a roadmap of miRNA transfer from brown adipose tissue (BAT) to other tissues, where they can act to regulate energy metabolism.
Open in Who Shared Issue with article?

Digital government and residents’ mental health in China: evidence on potential mechanisms and urban–rural heterogeneity

|
By Hao Ji, Xianguo Qu, Junyi Xin, Yingying Yu, Weiguang Pan
| Frontiers in Public Health Verified
Abstract Background: Digital government has become a critical component of contemporary public governance, yet its relationship with residents’ mental health remains insufficiently examined. This study investigates whether digital government development is associated with residents’ mental health in China and how this association varies across urban and rural populations.
Open in Who Shared Issue with article?

The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial

|
By Panpan Zhang, Zuoxing Niu, Hongqian Guo, Miao Zhang, Shusuan Jiang, Baoshan Cao, Xinfang Hou, Jian Zhang, Jiajia Yuan, Yujia Zhu, Yingying Yu, Caixia Sun, Peng Peng, Jean Fan, Jifang Gong, Jun L Zhou, Lin Shen, Chaohong He
| Nature Verified
Abstract Tinengotinib is a spectrum-selective multi-kinase inhibitor targeting FGFR1–3, JAK1/2, VEGFRs, and Aurora A/B kinases. This phase Ib/II clinical trial (NCT05253053) evaluated tinengotinib as monotherapy (Arm A, n = 53, in Chinese patients with advanced solid tumors) and in combination with atezolizumab (Arm B, n = 31, in patients with advanced biliary tract cancer).
Open in Who Shared Issue with article?
See all 38 licensed articles (42 Total)